1-[1-[4-amino-3-(6-methoxy-3-pyridinyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-7-fluoro-3-phenylquinolizin-4-one
C28H22FN7O2 — CID 141471396
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[1-[4-amino-3-(6-methoxy-3-pyridinyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-7-fluoro-3-phenylquinolizin-4-one
1-[1-[4-amino-3-(6-methoxy-3-pyridinyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-7-fluoro-3-phenylquinolizin-4-one (PubChem CID 141471396) has the molecular formula C28H22FN7O2 and a molecular weight of 507.53 g/mol. Its IUPAC name is 1-[1-[4-amino-3-(6-methoxy-3-pyridinyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-7-fluoro-3-phenylquinolizin-4-one.
Molecular Properties
| Compound Name | 1-[1-[4-amino-3-(6-methoxy-3-pyridinyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-7-fluoro-3-phenylquinolizin-4-one |
|---|---|
| PubChem CID | 141471396 |
| Molecular Formula | C28H22FN7O2 |
| Molecular Weight | 507.53 g/mol |
| Exact Mass | 507.18 |
| IUPAC Name | 1-[1-[4-amino-3-(6-methoxy-3-pyridinyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-7-fluoro-3-phenylquinolizin-4-one |
| SMILES | COc1ccc(-c2nn(C(C)c3cc(-c4ccccc4)c(=O)n4cc(F)ccc34)c3ncnc(N)c23)cn1 |
| InChI | InChI=1S/C28H22FN7O2/c1-16(20-12-21(17-6-4-3-5-7-17)28(37)35-14-19(29)9-10-22(20)35)36-27-24(26(30)32-15-33-27)25(34-36)18-8-11-23(38-2)31-13-18/h3-16H,1-2H3,(H2,30,32,33) |
| InChIKey | GSCQIPCXCRHRDQ-UHFFFAOYSA-N |
| XLogP | 4.51 |
| TPSA | 113.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 507.53 |
| LogP ≤ 5 | 4.51 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141471396 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.